Patent · US Active

Adjuvanted nanoparticulate influenza vaccine

US12370251B2 · kind B2 · utility

0Cited by

8References

20Claims

0Family size

Assignee

MERCIA PHARMA, INC. · US

Inventors

Peter Blackburn · New York, US
Stephen Grimes · Davis, US

Key dates

Filing date	Nov 5, 2010
Grant date	Jul 29, 2025
Priority date	—
Expiry date	Nov 5, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16234
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Vaccine compositions comprising influenza antigens formulated as nanoparticulate water in oil miniemulsions. The vaccines may be formulated at the point of use and are useful in emergency response conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.